mHealth Israel_ IP Strategy in China_Ehrlich & Fenster

11
IP Strategy in china Roy Melzer Patent Attorney Ehrlich & Fenster

Transcript of mHealth Israel_ IP Strategy in China_Ehrlich & Fenster

Page 1: mHealth Israel_ IP Strategy in China_Ehrlich & Fenster

IP Strategy in chinaRoy Melzer

Patent AttorneyEhrlich & Fenster

Page 2: mHealth Israel_ IP Strategy in China_Ehrlich & Fenster

Medical Devices and Pharmaceuticals Market Access

$1.2 billionExport of Pharmaceutical products from US to china2013

$2.7 billionExport of Medical Devices from US to china2013

China and the US affirm that significantly reducing the time-to-market for innovative pharmaceutical products and medical devices will benefit patients by allowing them to receive better treatment earlier

US, China Put Emphasis On IP Issues19/12/2014 BY WILLIAM NEW, INTELLECTUAL PROPERTY WATCH

Page 3: mHealth Israel_ IP Strategy in China_Ehrlich & Fenster
Page 4: mHealth Israel_ IP Strategy in China_Ehrlich & Fenster

http://china.ucsd.edu/_files/np-2015/Panel%201%20-%20LIAN_Larry.pdf

Introducing the USPTO China Resource Center and Various Examples of Empirical IP Data We AnalyzeOffice of Policy and International Affairs, US Patent & Trademark Office, May 19, 2015

SIPO Patent Application Filing Trend

Page 5: mHealth Israel_ IP Strategy in China_Ehrlich & Fenster

Patent Law enacted in China in 1984

3 Types of Patents:

•Invention patent•Utility Model patent - To encourage domestic IP innovators and protect small inventions•Industrial Design patent

http://www.wipo.int/edocs/mdocs/aspac/en/wipo_ip_kul_12/wipo_ip_kul_12_ref_t3d.pdf

Page 6: mHealth Israel_ IP Strategy in China_Ehrlich & Fenster

Main Differences with Invention System

Invention Utility Model

Subject Matter Product and Process Product Only

Exam System Early Publication and delayed substantive examination

Preliminary Examination

Protection Term 20 Years 10 Years

Novelty Absolute novelty Principle Absolute novelty principle

Inventiveness standard Has prominent substantive features. Represents a notable progress

Has substantive features. Represents progress

Practical applicability Can be made or used, can produce effective result

Can be made or used, can produce effective result

http://www.wipo.int/edocs/mdocs/aspac/en/wipo_ip_kul_12/wipo_ip_kul_12_ref_t3d.pdf

Page 7: mHealth Israel_ IP Strategy in China_Ehrlich & Fenster

Patenting Software in China

NON PATENTABLE subject matters objectionsrelated to computer programs

methods of calculation or rules of mathematical calculation

computer programs as such or computer programs recorded on computer-readable media

playing games rules and methods

http://www.jenkins.eu/news-and-publications/patent-issues-autumn-2014/patenting-software-in-china/

Page 8: mHealth Israel_ IP Strategy in China_Ehrlich & Fenster

In order to obtain appropriate patent protection for software inventions

Process for resolving a technical problem and reciting specific steps performed by way of executing computer programs to perform specific functions

Connections

between the

components and describes how each function of the computer program is performed by a corresponding component or group of components.

It is not necessary to define the components by their physical structures

Strict one-to-one correspondence between recited means and steps recited in the corresponding method claim

http://www.jenkins.eu/news-and-publications/patent-issues-autumn-2014/patenting-software-in-china/

Patenting Software in China

Page 9: mHealth Israel_ IP Strategy in China_Ehrlich & Fenster

Draft Amendments to China's Patent Law

This is a comprehensive revision in response to the concerns voiced by the National People Congress (NPC) of patent quality and enforcement matters, and to overall address matters such as reducing the time frame for patent administrative litigation,

refining procedures, and improving enforcement in the online environments.

http://www.hg.org/article.asp?id=35621

On April 1, 2015 the State

Intellectual Property Office (SIPO) released a revised draft

amendment to China’s Patent

Law

The supervision of administrative patent enforcement in eight provinces and regions by the NPC Standing

Committee, launched in 2014

The ongoing campaign to

address counterfeit and substandard

products

the renewed commitment to

amend the Patent SIPO’s desire to ensure its

administrative enforcement system is not sidelined by recent efforts to improve

the judicial adjudication of high technology intellectual

property cases.

Page 10: mHealth Israel_ IP Strategy in China_Ehrlich & Fenster

Draft Amendments to China's Patent Law

expanding patentable subjects and extending the patent term.The duration of a patent design has increased from 10 years to 15 years under Article 42, which finally brings it in line with the requirement of at least 15 years under the relevant Hague Agreements, therefore attracting potential international applicants

Judicial and administrative authorities powers of investigation and evidence collection

CompensationThe existing Patent Law allows the patent administrative authority to mediate disputes in relation to patent matters, and provides for legal action before the People’s Court if the mediation fails. However, in practice, administrative mediation in regards to compensation matters are unenforceable, therefore resulting in further burdens on the patentee and a waste on administrative and judicial resources.

Delegation of duty to investigate and punitive damagesIn many cases, repeated infringement and infringement by multiple parties occur frequently, therefore patentees must pursue legal actions against each infringer on an individual basis.

Page 11: mHealth Israel_ IP Strategy in China_Ehrlich & Fenster

Roy MelzerPatent Attorney

[email protected]